Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abdel Kareem Azab

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Future Oncology (London, England)|June 23, 2016
3D tissue-engineered bone marrow: what does this mean for the treatment of multiple myeloma?Pilar de la Puente, Abdel Kareem Azab
European Journal of Haematology|February 17, 2017
Nanoparticle delivery systems, general approaches, and their implementation in multiple myelomaPilar de la Puente, Abdel Kareem Azab
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 11, 2014
Delivery systems for brachytherapyPilar de la Puente, Abdel Kareem Azab
Trends in Molecular Medicine|June 15, 2023
Fatty acid binding proteins in multiple myelomaCamila Diedrich, Mina Maksimos, Abdel Kareem Azab
Leukemia & Lymphoma|April 1, 2014
The role of P-glycoprotein in drug resistance in multiple myelomaJoseph Abraham, Noha N Salama, Abdel Kareem Azab
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 12, 2005
Targeting normal and neoplastic tissues in the rat jejunum and colon with boronated, cationic acrylamide copolymersAbdel-Kareem Azab, Morris Srebnik, Victoria Doviner, et al.
Pharmaceutical Research|October 26, 2007
The metastatic stage-dependent mucosal expression of sialic acid is a potential marker for targeting colon cancer with cationic polymersAbdel Kareem Azab, Jackie Kleinstern, Morris Srebnik, et al.
Blood Cancer Journal|April 7, 2023
E-selectin-targeting lipid nanoparticles improve therapeutic efficacy and reduce side effects of bortezomib in multiple myelomaMina Maksimos, Barbara Muz, John L Magnani, et al.
Pharmaceutical Research|June 3, 2015
Advancements in Tumor Targeting Strategies for Boron Neutron Capture TherapyMicah John Luderer, Pilar de la Puente, Abdel Kareem Azab
Hypoxia (Auckland, N.Z.)|October 25, 2016
The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapyBarbara Muz, Pilar de la Puente, Feda Azab, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Future Oncology (London, England)|June 23, 2016
3D tissue-engineered bone marrow: what does this mean for the treatment of multiple myeloma?Pilar de la Puente, Abdel Kareem Azab
European Journal of Haematology|February 17, 2017
Nanoparticle delivery systems, general approaches, and their implementation in multiple myelomaPilar de la Puente, Abdel Kareem Azab
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 11, 2014
Delivery systems for brachytherapyPilar de la Puente, Abdel Kareem Azab
Trends in Molecular Medicine|June 15, 2023
Fatty acid binding proteins in multiple myelomaCamila Diedrich, Mina Maksimos, Abdel Kareem Azab
Leukemia & Lymphoma|April 1, 2014
The role of P-glycoprotein in drug resistance in multiple myelomaJoseph Abraham, Noha N Salama, Abdel Kareem Azab
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 12, 2005
Targeting normal and neoplastic tissues in the rat jejunum and colon with boronated, cationic acrylamide copolymersAbdel-Kareem Azab, Morris Srebnik, Victoria Doviner, et al.
Pharmaceutical Research|October 26, 2007
The metastatic stage-dependent mucosal expression of sialic acid is a potential marker for targeting colon cancer with cationic polymersAbdel Kareem Azab, Jackie Kleinstern, Morris Srebnik, et al.
Blood Cancer Journal|April 7, 2023
E-selectin-targeting lipid nanoparticles improve therapeutic efficacy and reduce side effects of bortezomib in multiple myelomaMina Maksimos, Barbara Muz, John L Magnani, et al.
Pharmaceutical Research|June 3, 2015
Advancements in Tumor Targeting Strategies for Boron Neutron Capture TherapyMicah John Luderer, Pilar de la Puente, Abdel Kareem Azab
Hypoxia (Auckland, N.Z.)|October 25, 2016
The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapyBarbara Muz, Pilar de la Puente, Feda Azab, et al.
Pageof 9